A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
The objective of this study is to compare how accurately the Xpert MTB/RIF assay Ct value at diagnosis and the AI-based tuberculosis activity score predict the treatment outcome of rifampin-susceptible pulmonary tuberculosis patients. As a retrospective observational study, data from patients diagnosed with rifampin susceptible pulmonary tuberculosis through the Xpert MTB/RIF assay performed on sputum in 2019 at the participating institutions will be analyzed (up to 900 people).
Inclusion Criteria:
Exclusion Criteria:
yimjj@snu.ac.kr+82-2-2072-2059
dr.hjkim@snubh.org+82317877844